🧫
L-carnitine rescue experiments in metabolic pathway
active
experiment
Created: 2026-04-10T22:48:37
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-16ff30e7-2c46-4709-83f6-9e93dcedd00e
🧫 Experiment Protocol
Exploratorychronic kidney diseaseACAT1ACAT1 knockdown with L-carnitine supplementationproposed
Rescue experiments using L-carnitine supplementation were conducted to validate the metabolic pathway downstream of ACAT1. After ACAT1 knockdown abolished hyperoside's benefits, L-carnitine was administered to determine if it could restore the metabolic flux and mitochondrial improvements. This experimental design tested whether the ACAT1-L-carnitine metabolic axis is crucial for hyperoside's mechanism of action. The results showed partial restoration of benefits, confirming the pathway's functional relevance and suggesting L-carnitine as a key metabolic intermediate.
PRIMARY OUTCOME
partial restoration of metabolic and mitochondrial benefits
EXPECTED OUTCOMES
L-carnitine would partially rescue the effects lost by ACAT1 knockdown
SUCCESS CRITERIA
measurable restoration of metabolic parameters and mitochondrial function
PROTOCOL
ACAT1 knockdown, L-carnitine supplementation, assessment of metabolic flux and mitochondrial function
Source: PMID 41903436 ↗
🧫 Experiment Extras
PATHWAY
ACAT1-l-carnitine-SIRT3 axis, l-carnitine-dependent metabolic flux
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.